About the Cover

Oncology

• Clinical

  • You have access

    The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer

    Jiajun Liu, Rengyun Liu, Xiaopei Shen, Guangwu Zhu, Biao Li and Mingzhao Xing

    Journal of Nuclear Medicine February 1, 2020, 61 (2) 177-182; DOI: https://doi.org/10.2967/jnumed.119.227652
  • You have access

    Prospective Comparison of PET Imaging with PSMA-Targeted ¹⁸F-DCFPyL Versus Na¹⁸F for Bone Lesion Detection in Patients with Metastatic Prostate Cancer

    Steven P. Rowe, Xin Li, Bruce J. Trock, Rudolf A. Werner, Sarah Frey, Michael DiGianvittorio, J. Keith Bleiler, Diane K. Reyes, Rehab Abdallah, Kenneth J. Pienta, Michael A. Gorin and Martin G. Pomper

    Journal of Nuclear Medicine February 1, 2020, 61 (2) 183-188; DOI: https://doi.org/10.2967/jnumed.119.227793

  • BRIEF COMMUNICATION

    • You have access

      Can the Injected Dose Be Reduced in ⁶⁸Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection?

      Isabel Rauscher, Wolfgang P. Fendler, Thomas A. Hope, Andrew Quon, Stephan G. Nekolla, Jeremie Calais, Antonia Richter, Bernhard Haller, Ken Herrmann, Wolfgang A. Weber, Johannes Czernin and Matthias Eiber

      Journal of Nuclear Medicine February 1, 2020, 61 (2) 189-193; DOI: https://doi.org/10.2967/jnumed.119.227207
  • You have access

    Detection Rate and Localization of Prostate Cancer Recurrence Using ⁶⁸Ga-PSMA-11 PET/MRI in Patients with Low PSA Values ≤ 0.5 ng/mL

    Benedikt Kranzbühler, Julian Müller, Anton S. Becker, Helena I. Garcia Schüler, Urs Muehlematter, Christian D. Fankhauser, Sarah Kedzia, Matthias Guckenberger, Philipp A. Kaufmann, Daniel Eberli and Irene A. Burger

    Journal of Nuclear Medicine February 1, 2020, 61 (2) 194-201; DOI: https://doi.org/10.2967/jnumed.118.225276
  • You have access

    An ¹⁸F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with ¹⁸F-JK-PSMA-7 During the First Year of Application

    Felix Dietlein, Melanie Hohberg, Carsten Kobe, Boris D. Zlatopolskiy, Philipp Krapf, Heike Endepols, Philipp Täger, Jochen Hammes, Axel Heidenreich, Bernd Neumaier, Alexander Drzezga and Markus Dietlein

    Journal of Nuclear Medicine February 1, 2020, 61 (2) 202-209; DOI: https://doi.org/10.2967/jnumed.119.229542
  • You have access

    Lesion Detection and Interobserver Agreement with Advanced Image Reconstruction for ¹⁸F-DCFPyL PET/CT in Patients with Biochemically Recurrent Prostate Cancer

    Bernard H.E. Jansen, Robin W. Jansen, Maurits Wondergem, Sandra Srbljin, John M.H. de Klerk, Birgit I. Lissenberg-Witte, André N. Vis, Reindert J.A. van Moorselaar, Ronald Boellaard, Otto S. Hoekstra and Daniela E. Oprea-Lager

    Journal of Nuclear Medicine February 1, 2020, 61 (2) 210-216; DOI: https://doi.org/10.2967/jnumed.118.222513

  • BRIEF COMMUNICATION

    • You have access

      Tumor-to-Blood Ratio for Assessment of Somatostatin Receptor Density in Neuroendocrine Tumors Using ⁶⁸Ga-DOTATOC and ⁶⁸Ga-DOTATATE

      Ezgi Ilan, Irina Velikyan, Mattias Sandström, Anders Sundin and Mark Lubberink

      Journal of Nuclear Medicine February 1, 2020, 61 (2) 217-221; DOI: https://doi.org/10.2967/jnumed.119.228072